TLSI
TriSalus Life Sciences Inc.
4.60$
-7.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 92.8% | 78.3% | 84.8% | 86.2% | 91.3% | |
| 80.1% | 42.8% | 47.9% | 35.6% | 57.9% | |
| 80.1% | 42.8% | 47.9% | 35.6% | 57.9% | |
| 3.6% | 7.1% | 14.4% | 21.2% | 18.6% | |
| 3.4% | 6.7% | 10.3% | 16.9% | 8.7% | |
| 2.1% | 3.6% | 4.6% | – | – | |
| 18.3% | 156.0% | 210.0% | 208.0% | 195.8% | |
| 16.8% | 147.1% | 59.7% | 42.7% | 32.5% | |
| 111.5% | 1.7% | 1.4% | 0.9% | 0.5% | |
| 3.4% | 22.5% | 13.8% | 9.5% | 8.5% | |
| – | – | – | 92.1% | 93.5% | |
| 81.7% | -56.0% | -110.0% | -108.0% | -95.8% | |
| -360.3% | -847.3% | -1,014.3% | -1,166.2% | -935.7% | |
| 82.6% | 134.6% | 107.6% | 110.6% | 107.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.